Archives

by in
Entry Author Date Location
GreatPoint, Enanta, NextView, & More Boston Dealmakers 02/22/12 Boston
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Hydra Makes Progress in Pain With First Trial and New Partnership 02/15/12 Boston
Report: ATV Trims Staff 06/13/11 Boston
Genzyme, After Months of Holding Out, Agrees to be Sold to Sanofi-Aventis for $20.1B 02/16/11 Boston
Build it Boldly, and Pharma Will Come—and More Wisdom from Boston’s Biotech and Pharma Elite at Xconomy Forum 11/05/09 Boston
Why is Pharma Betting So Big on Innovation in Boston? 10/27/09 Boston
Flexion Pulls in $33M, Cubist Teams With Hydra, Charles River Makes Cuts, & More Boston-Area Life Sciences News 10/21/09 Boston
Hydra, Cubist Seek New Pain Drugs 10/19/09 Boston
U.S. Venture Funding Plummets (Yada Yada), But New England Less So—Region’s Top 10 Deals of Q1 04/20/09 Boston
Pfizer Bid for Wyeth Will Stall Mass. Biotech Deals, CEO Says, State Official Still Sees Growth 01/27/09 Boston
Vertex Stays Put, Hydra Handed $22M, Sequenom Still Pursuing Exact Sciences Acquisition, & More Boston-Area Life Sciences News 01/21/09 Boston
Hydra Biosciences Raises $22M to Create New Pain Relievers With Fewer Side Effects 01/16/09 Boston
Hydra Biosciences Secures $22,000,000 Series D Funding Round 01/16/09 Boston
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms 12/12/08 San Diego
RXi’s Debut, Sirtris’ Surprising Deal, Hydra’s Big Financing Round, & More of the Last Week in Life Sciences 03/19/08 Boston
GreenFuel Strikes A Deal, Sirtris Teams with Bayer on Crops, Salient Files for an IPO, & More Deals News 03/17/08 Boston
Hydra Biosciences Obtains $17,016,100 Series C Round 03/13/08 Boston
Hydra Biosciences Lands $16,983,900 New Round 12/31/07 Boston
Page 1 of 1